Q2FY23 Quarterly Result Announced for Krishna Institute of Medical Sciences Ltd.
Krishna Institute of Medical Sciences announced Q2FY23 results: Consolidated revenue from operations grew by 13.8% QoQ basis to Rs 5,641 million, Ex Nagpur grew by 11%. Consolidated adjusted EBITDA (Excluding other income, INDAS adjustments, and an old case of luxury tax payment) grew by 14.5% on a QoQ basis to Rs 1,502 million, Ex Nagpur grew by 13.4% to Rs 1,488 million. Consolidated adjusted EBITDA margin stands at 26.6%, Ex Nagpur stands at 27.1% (QoQ improvement of 0.6%). The group continues to have a very strong balance sheet along with healthy operating cash flow and has built a strong financial foundation for the next phase of growth. Commenting on the performance, Dr. B. Bhaskara Rao, Chairman & Managing Director said, "It has been a very productive quarter for us. We set foot in Nagpur with the acquisition of Kingsway Hospitals (renamed now as KIMS-Kingsway Hospitals). Our continuous commitment to provide the best medical technology to our patients saw us acquire 2 advanced robotic machines for Orthopedics, a state-of-the-art OCT machine and a Cardiac laser for the benefit of Cardiac patients and an EVIS X1 endoscopy unit with AI for Gastroenterology Centre. But more than this, our biggest satisfaction is when we see our patients going back home healthy. We are confident that we will be able to meet the expectations set for FY23. We attracted excellent clinical talent across the group. We now have a strength of over 1,600 doctors." Result PDF11-11-2022